Solanum incanum extract (also known as SR-T100), has been shown to downregulate c/EBPβ and COL11A1 expression, thereby sensitizing melanoma and ovarian cancer cells to cisplatin [101]. This evidence concerns the gene CEBPB and ovarian cancer.